Patient P-02458
Synthetic patientMETA-24 · Day 94 · 35–44 · M · baseline S16Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
4%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S16
- Day 67 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 67.
Primary contributors, last 14 days
- GI instability-33
- Nutritional resilience+27
- Inflammatory activity-26
- Toxicity-24
- Treatment adherence-7
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable69 min
improving · +5.0 vs previous 14 d
Sleep duration
Wearable7.7 h
stable · +0.3 vs previous 14 d
Energy level
Daily log7.9/10
improving · +1.0 vs previous 14 d
Steps
Wearable6,909
improving · +675 vs previous 14 d
GI burden
Companion4.9/100
improving · -21.4 vs previous 14 d
Adherence
Companion85.6 %
worsening · -3.9 vs previous 14 d
Sleep quality
Wearable72/100
improving · +10.5 vs previous 14 d
Glucose, CGM daily mean
CGM126 mg/dL
improving · -7.1 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 95 from the failing basin, 19 from restoration.
Good elements to keep
- Protein (supports)perturbation · steering +14.6
- Butyrate producers intacthidden · steering +7.5
- Daily walks resumedperturbation · steering +3.3
- Proteinsupporter · GI -6.6 next day
Main detractors to watch
- Poor metabolizerhidden · steering -12.7
- Caffeineperturbation · steering -11
- Antibiotic courseperturbation · steering -4.7
- Dietary driftperturbation · steering -2.6
- Caffeinedetractor · GI +6.3 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6.6supporter · 95%
- Caffeine+6.3detractor · 95%
- Histamine load+1.4no signal · 22%
- Ultra-processed food-1.4no signal · 26%
- Simple carbohydrates-1.3no signal · 15%
- Alcohol-1.3no signal · 24%
- Dietary fat load+0.4no signal · 15%
- Insoluble fibre-0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.7 · butyrate capacity 81/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 57 ms
- Sleep
- 7.5 h
- Steps
- 5,260
- Resting HR
- 71 bpm
Daily log: GI score 5, nutritional resilience 75, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02285 | 29% | S14 | AD-05 | no change | 39 |
| P-02031 | 28% | S12 | AD-05 | improved | 47 |
| P-02483 | 31% | S06 | BR-03 | no change | 64 |
| P-02267 | 30% | S09 | BR-03 | no change | 45 |
| P-02282 | 30% | S01 | BR-03 | no change | 88 |
| P-02280 | 29% | S07 | BR-03 | no change | 50 |
| P-02462 | 33% | S12 | DT-01 | improved | 65 |
| P-02491 | 33% | S09 | DT-01 | no change | 65 |
| P-02518 | 33% | S17 | DT-01 | improved | 68 |
| P-02586 | 33% | S18 | DT-01 | improved | 56 |
| P-02218 | 32% | S01 | DT-01 | improved | 61 |
| P-02126 | 31% | S16 | DT-01 | improved | 59 |